NEUROD1 and type 2 diabetes mellitus: This work can not only advances our understanding of the Ex-4 effect on the DE in T2D, it also adds a new dimension in applying the Wnt/β-catenin pathway, transcription factor NeuroD1, and the Ins2 gene as new intervention targets to the therapeutic exploration of DE brain changes in T2D.